2 days Ago By ABMN Staff
Clover Health Investments, Corp. ( NASDAQ:CLOV – Free Report ) – Equities researchers at Leerink Partnrs increased their Q2 2025 earnings per share estimates for Clover Health Investments in a research report issued on Wednesday, November 6th. Leerink Partnrs analyst W.
Mayo now anticipates that the company will post earnings of $0.03 per share for the quarter, up from their prior estimate of $0.02.
The consensus estimate for Clover Health Investments’ current full-year earnings is ($0.13) per share. Separately, UBS Group initiated coverage on Clover Health Investments in a report on Monday, October 7th.
They issued a “neutral” rating and a $4.00 target price for the company. Clover Health Investments Stock Performance Shares of CLOV stock opened at $3.
41 on Friday. The company has a market cap of $1.70 billion, a P/E ratio of -17.
05 and a beta of 2.03. The stock has a 50 day simple moving average of $3.
47 and a two-hundred day simple moving average of $2.17. Clover Health Investments has a fifty-two week low of $0.
61 and a fifty-two week high of $4.71. Institutional Investors Weigh In On Clover Health Investments Several hedge funds and other institutional investors have recently modified their holdings of the company.
Connor Clark & Lunn Investment Management Ltd. increased its holdings in shares of Clover Health Investments by 75.7% during the third quarter.
Connor Clark & Lunn Investment Management Ltd. now owns 1,128,171 shares of the company’s stock valued at $3,181,000 after acquiring an additional 485,987 shares in the last quarter. KBC Group NV bought a new stake in shares of Clover Health Investments during the third quarter valued at approximately $53,000.
Sigma Planning Corp bought a new stake in shares of Clover Health Investments during the third quarter valued at approximately $29,000. Concurrent Investment Advisors LLC bought a new stake in shares of Clover Health Investments during the third quarter valued at approximately $28,000. Finally, Forum Financial Management LP increased its holdings in shares of Clover Health Investments by 33.
8% during the third quarter. Forum Financial Management LP now owns 16,077 shares of the company’s stock valued at $45,000 after acquiring an additional 4,061 shares in the last quarter. Institutional investors own 19.
77% of the company’s stock. About Clover Health Investments ( Get Free Report ) Clover Health Investments, Corp. provides medicare advantage plans in the United States.
It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Recommended Stories Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.
com's FREE daily email newsletter ..
